These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19717338)

  • 1. Making sense of nonsense GABA(A) receptor mutations associated with genetic epilepsies.
    Kang JQ; Macdonald RL
    Trends Mol Med; 2009 Sep; 15(9):430-8. PubMed ID: 19717338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X.
    Kang JQ; Shen W; Macdonald RL
    J Neurosci; 2009 Mar; 29(9):2833-44. PubMed ID: 19261879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mRNA surveillance and endoplasmic reticulum quality control processes alter biogenesis of mutant GABAA receptor subunits associated with genetic epilepsies.
    Macdonald RL; Kang JQ
    Epilepsia; 2012 Dec; 53 Suppl 9(0 9):59-70. PubMed ID: 23216579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trafficking-deficient mutant GABRG2 subunit amount may modify epilepsy phenotype.
    Kang JQ; Shen W; Macdonald RL
    Ann Neurol; 2013 Oct; 74(4):547-59. PubMed ID: 23720301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Channelopathies as a genetic cause of epilepsy.
    Mulley JC; Scheffer IE; Petrou S; Berkovic SF
    Curr Opin Neurol; 2003 Apr; 16(2):171-6. PubMed ID: 12644745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of nonsense mutation in GABRG2 with abnormal trafficking of GABAA receptors in severe epilepsy.
    Ishii A; Kanaumi T; Sohda M; Misumi Y; Zhang B; Kakinuma N; Haga Y; Watanabe K; Takeda S; Okada M; Ueno S; Kaneko S; Takashima S; Hirose S
    Epilepsy Res; 2014 Mar; 108(3):420-32. PubMed ID: 24480790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GABRG2 nonsense mutation, Q40X, associated with Dravet syndrome activated NMD and generated a truncated subunit that was partially rescued by aminoglycoside-induced stop codon read-through.
    Huang X; Tian M; Hernandez CC; Hu N; Macdonald RL
    Neurobiol Dis; 2012 Oct; 48(1):115-23. PubMed ID: 22750526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genes and mutations in idiopathic epilepsy.
    Steinlein OK
    Am J Med Genet; 2001; 106(2):139-45. PubMed ID: 11579434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Genetic background of epilepsies].
    Kelemen A; Szucs A; Rásonyi G; Janszky J; Holló A; Halász P
    Ideggyogy Sz; 2004 May; 57(5-6):141-51. PubMed ID: 15264690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes associated with idiopathic epilepsies: a current overview.
    Lu Y; Wang X
    Neurol Res; 2009 Mar; 31(2):135-43. PubMed ID: 19298753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Pathogenic Basis for GABRG2 Mutations Associated With a Spectrum of Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome.
    Kang JQ; Macdonald RL
    JAMA Neurol; 2016 Aug; 73(8):1009-16. PubMed ID: 27367160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetics of human epilepsy.
    Scheffer IE; Berkovic SF
    Trends Pharmacol Sci; 2003 Aug; 24(8):428-33. PubMed ID: 12915053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsense mutations in the rhodopsin gene that give rise to mild phenotypes trigger mRNA degradation in human cells by nonsense-mediated decay.
    Roman-Sanchez R; Wensel TG; Wilson JH
    Exp Eye Res; 2016 Apr; 145():444-449. PubMed ID: 26416182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deleterious Rare Variants Reveal Risk for Loss of GABAA Receptor Function in Patients with Genetic Epilepsy and in the General Population.
    Hernandez CC; Klassen TL; Jackson LG; Gurba K; Hu N; Noebels JL; Macdonald RL
    PLoS One; 2016; 11(9):e0162883. PubMed ID: 27622563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The nonsense-mediated mRNA decay pathway triggers degradation of most BRCA1 mRNAs bearing premature termination codons.
    Perrin-Vidoz L; Sinilnikova OM; Stoppa-Lyonnet D; Lenoir GM; Mazoyer S
    Hum Mol Genet; 2002 Nov; 11(23):2805-14. PubMed ID: 12393792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of idiopathic epilepsies.
    Hirose S; Mitsudome A; Okada M; Kaneko S;
    Epilepsia; 2005; 46 Suppl 1():38-43. PubMed ID: 15816978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new paradigm of channelopathy in epilepsy syndromes: intracellular trafficking abnormality of channel molecules.
    Hirose S
    Epilepsy Res; 2006 Aug; 70 Suppl 1():S206-17. PubMed ID: 16860540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine CGA codons as a source of nonsense mutations: a possible role in multivariant gene expression, control of mRNA quality, and aging.
    Romanov GA; Sukhoverov VS
    Mol Genet Genomics; 2017 Oct; 292(5):1013-1026. PubMed ID: 28523359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and Molecular Regulation of Extrasynaptic GABA-A Receptors in the Brain: Therapeutic Insights for Epilepsy.
    Chuang SH; Reddy DS
    J Pharmacol Exp Ther; 2018 Feb; 364(2):180-197. PubMed ID: 29142081
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.